CREDIT SUISSE AG/ - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 119 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
20
-99.9%
0.00%
Q1 2022$180,000
-30.5%
20,809
+14.8%
0.00%
Q4 2021$259,000
+82.4%
18,123
+51.0%
0.00%
Q1 2014$142,000
+13.6%
12,000
-21.4%
0.00%
Q2 2013$125,00015,2720.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 801,242$3,876,0000.50%
ARMISTICE CAPITAL, LLC 624,000$3,039,0000.18%
Rossmore Private Capital 15,061$73,0000.03%
Sterling Investment Advisors, Ltd. 3,150$15,0000.01%
Squarepoint Ops LLC 14,500$71,0000.00%
JFS WEALTH ADVISORS, LLC 500$2,0000.00%
Close Asset Management Ltd 2,000$10,0000.00%
GROUP ONE TRADING, L.P. 16,900$82,0000.00%
SIMPLEX TRADING, LLC 547$2,0000.00%
Tower Research Capital LLC (TRC) 861$4,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders